Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,818 | 103 | 64.9% |
| Current or prospective ownership or investment interest | $668.93 | 1 | 23.9% |
| Education | $314.24 | 5 | 11.2% |
| Unspecified | $0 | 1 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Physician Discoveries, LLC | $668.93 | 2 | $0 (2017) |
| Astellas Pharma US Inc | $645.08 | 40 | $0 (2021) |
| Kerecis Limited | $292.92 | 3 | $0 (2024) |
| Janssen Biotech, Inc. | $236.37 | 10 | $0 (2022) |
| PFIZER INC. | $137.39 | 9 | $0 (2019) |
| NeoTract Inc. | $132.36 | 3 | $0 (2018) |
| Amgen Inc. | $127.43 | 8 | $0 (2018) |
| AbbVie, Inc. | $115.63 | 8 | $0 (2018) |
| Ferring Pharmaceuticals Inc. | $98.95 | 6 | $0 (2018) |
| Endo Pharmaceuticals Inc. | $74.56 | 5 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $222.82 | 4 | Kerecis Limited ($185.47) |
| 2023 | $107.45 | 1 | Kerecis Limited ($107.45) |
| 2022 | $85.00 | 1 | Janssen Biotech, Inc. ($85.00) |
| 2021 | $204.86 | 3 | Astellas Pharma US Inc ($204.86) |
| 2019 | $41.45 | 3 | PFIZER INC. ($29.26) |
| 2018 | $666.38 | 40 | Astellas Pharma US Inc ($149.44) |
| 2017 | $1,473 | 58 | Physician Discoveries, LLC ($668.93) |
All Payment Transactions
110 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | Kerecis Limited | Kerecis Omega3 SurgiClose (Device), Kerecis Omega3 Marigen, Kerecis Omega3 Marigen | Food and Beverage | Cash or cash equivalent | $30.25 | General |
| Category: Wound Care | ||||||
| 09/23/2024 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: LithoVue_URO | ||||||
| 06/28/2024 | Kerecis Limited | Kerecis Omega3 SurgiClose (Device), Kerecis Omega3 Marigen, Kerecis Omega3 Marigen | Food and Beverage | Cash or cash equivalent | $155.22 | General |
| Category: Wound Care | ||||||
| 01/14/2024 | Siemens Medical Solutions USA, Inc. | ACUSON Juniper Diagnostic Ultrasound System (Device) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: US - Ultrasound Systems | ||||||
| 08/22/2023 | Kerecis Limited | Kerecis Omega3 SurgiClose (Device), Kerecis Omega3 GraftGuide, Kerecis Omega3 SurgiClose | Food and Beverage | Cash or cash equivalent | $107.45 | General |
| Category: Wound Care | ||||||
| 06/08/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Education | In-kind items and services | $85.00 | General |
| Category: Oncology | ||||||
| 09/01/2021 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.99 | General |
| 08/05/2021 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $4.88 | General |
| Category: ONCOLOGY | ||||||
| 02/25/2021 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.99 | General |
| 07/19/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: UROLOGY | ||||||
| 03/18/2019 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 03/05/2019 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 11/29/2018 | AbbVie, Inc. | Lupron (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Endocrinology | ||||||
| 11/26/2018 | Ferring Pharmaceuticals Inc. | NOCDURNA (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: UROLOGY | ||||||
| 11/20/2018 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: ONCOLOGY | ||||||
| 11/16/2018 | NeoTract Inc. | UroLift (Device) | Food and Beverage | In-kind items and services | $46.64 | General |
| Category: Urology | ||||||
| 11/14/2018 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: UROLOGY | ||||||
| 11/12/2018 | Ferring Pharmaceuticals Inc. | NOCDURNA (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: UROLOGY | ||||||
| 11/07/2018 | NeoTract Inc. | UroLift (Device) | Food and Beverage | In-kind items and services | $53.99 | General |
| Category: Urology | ||||||
| 10/30/2018 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Oncology | ||||||
| 10/17/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: UROLOGY | ||||||
| 10/10/2018 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Endocrinology | ||||||
| 10/04/2018 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: UROLOGY | ||||||
| 10/02/2018 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Oncology | ||||||
| 09/25/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,369 | 1,947 | $418,194 | $92,209 |
| 2022 | 17 | 1,443 | 3,563 | $433,357 | $104,240 |
| 2021 | 23 | 1,663 | 4,093 | $497,441 | $125,024 |
| 2020 | 24 | 1,538 | 4,279 | $464,732 | $109,221 |
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 328 | 425 | $79,667 | $25,091 | 31.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 173 | 238 | $69,258 | $20,717 | 29.9% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 16 | 105 | $119,700 | $14,388 | 12.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 53 | 63 | $45,297 | $10,820 | 23.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $13,068 | $2,971 | 22.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 25 | 39 | $7,800 | $2,345 | 30.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 16 | $6,800 | $1,893 | 27.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 12 | $6,744 | $1,582 | 23.5% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 11 | 12 | $19,140 | $1,448 | 7.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 15 | $6,045 | $1,436 | 23.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 285 | 380 | $5,320 | $1,280 | 24.1% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 193 | 303 | $5,114 | $1,190 | 23.3% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 11 | 11 | $5,302 | $1,124 | 21.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 15 | 28 | $3,416 | $1,054 | 30.9% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 14 | 15 | $4,455 | $1,026 | 23.0% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 18 | 39 | $4,329 | $928.50 | 21.4% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 35 | 45 | $3,375 | $876.42 | 26.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $5,115 | $849.74 | 16.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 81 | 107 | $5,457 | $759.51 | 13.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 36 | $2,536 | $382.35 | 15.1% |
| 81015 | Urinalysis using microscope | Office | 2023 | 15 | 16 | $256.00 | $47.84 | 18.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 350 | 471 | $75,665 | $29,310 | 38.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 208 | 295 | $70,243 | $25,955 | 37.0% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 19 | 165 | $188,100 | $23,126 | 12.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 42 | 55 | $36,445 | $9,168 | 25.2% |
About Dr. Atlee Johnson, MD
Dr. Atlee Johnson, MD is a Urology healthcare provider based in Salisbury, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1194709675.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Atlee Johnson, MD has received a total of $2,801 in payments from pharmaceutical and medical device companies, with $222.82 received in 2024. These payments were reported across 110 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,818).
As a Medicare-enrolled provider, Johnson has provided services to 6,013 Medicare beneficiaries, totaling 13,882 services with total Medicare billing of $430,694. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Salisbury, NC
- Active Since 11/30/2005
- Last Updated 08/18/2021
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1194709675
Products in Payments
- Kerecis Omega3 SurgiClose (Device) $292.92
- Myrbetriq (Drug) $278.59
- XTANDI (Drug) $132.93
- UroLift (Device) $132.36
- MYRBETRIQ (Drug) $128.90
- Prolia (Biological) $127.43
- ZYTIGA (Drug) $106.34
- ERLEADA (Drug) $85.00
- XIAFLEX (Biological) $74.56
- Xofigo (Drug) $71.08
- FIRMAGON (Drug) $65.31
- Androgel (Drug) $64.09
- Lupron (Drug) $51.54
- Erleada (Drug) $45.03
- Aquoral (Device) $37.46
- NOCDURNA (Drug) $33.64
- VIAGRA (Drug) $29.84
- LithoVue (Device) $22.39
- Natesto (Drug) $19.58
- GRAFIX/GRAFIXPL/STRAVIX (Biological) $18.45
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Salisbury
Dr. Alyssa Gracely, M.d, M.D
Urology — Payments: $22,409
Dr. Mark Shimko, Md, MD
Urology — Payments: $5,623
Jason Greenlee, D.o, D.O
Urology — Payments: $5,442
Robert Bertram, Md, MD
Urology — Payments: $2,874
Harold Genvert, Md, MD
Urology — Payments: $2,020
Dr. Wayne Cline, Md, MD
Urology — Payments: $1,728